Skip to main content
Konstantinos Arnaoutakis, MD, Oncology, Little Rock, AR, UAMS Medical Center

KonstantinosArnaoutakisMD

Oncology Little Rock, AR

Associate Professor, Internal Medicine, University of Arkansas COM

Dr. Arnaoutakis is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Arnaoutakis' full profile

Already have an account?

  • Office

    UAMS Medical Center
    449 Jack Stephens Drive Winthrop P. Rockefeller Cancer Institute, Seventh Floor
    Little Rock, AR 72205
    Phone+1 501-686-8530
  • Is this information wrong?

Education & Training

  • St Elizabeth's Medical Center
    St Elizabeth's Medical CenterFellowship, Hematology and Medical Oncology, 2006 - 2009
  • Albany Medical Center
    Albany Medical CenterResidency, Internal Medicine, 2003 - 2006
  • University of Patras School of Medicine
    University of Patras School of MedicineClass of 1998

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2006 - 2025
  • AR State Medical License
    AR State Medical License 2009 - 2024
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2014

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • New UAMS Baptist Health Cancer Center Opens in North Little Rock
    New UAMS Baptist Health Cancer Center Opens in North Little RockAugust 30th, 2021
  • OncLive® Presents State of the Science Summit™ on Non-Small Cell Lung Cancer
    OncLive® Presents State of the Science Summit™ on Non-Small Cell Lung CancerJune 12th, 2019
  • Upfront Osimertinib Shows No Survival Advantage but Slows Brain Progression in EGFR-Mutant NSCLC Trial
    Upfront Osimertinib Shows No Survival Advantage but Slows Brain Progression in EGFR-Mutant NSCLC TrialMarch 12th, 2024

Professional Memberships

Hospital Affiliations